Results 191 to 200 of about 854,863 (214)

Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. [PDF]

Oncol Res
Tsubaki M, Matsuo T, Komori R.
europepmc   +1 more source

P4HA3-mediated hydroxylation of SLC7A11 drives tyrosine kinase inhibitor resistance by suppressing ferroptosis in clear cell renal cell carcinoma. [PDF]

Redox Biol
Chen Y, Zhang G, Yang R, Li Y, Song H, Chen Z, Cai H, Li Q, Fang C, Huang J, Xing S, Yang X, Xu D, Chen L.   +13 more
europepmc   +1 more source

Brugada Phenocopy Associated With the Tyrosine Kinase Inhibitor Avapritinib During Febrile Illness. [PDF]

JACC Case Rep
Haque OI, Ur Rehman O, Othman L, Mozayan M, Aronis KN.   +4 more
europepmc   +1 more source

Affino-Proteomic Analysis of Bumped Kinase Inhibitor BKI-1708 in <i>Toxoplasma gondii</i> and Human Fibroblast Host Cells. [PDF]

Microorganisms
Ferreira de Sousa MC, Müller J, Heller M, Uldry AC, Braga-Lagache S, Ojo KK, Voorhis WCV, Hemphill A.   +7 more
europepmc   +1 more source

Exploratory multiomics analysis identifies WDR17 as a potential biomarker of tyrosine kinase inhibitor resistance in lung adenocarcinoma. [PDF]

Discov Oncol
Xu Y, Li L, Li Z, Yang Y, Xing H, Ma X, Zhang X.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors

Annals of Oncology, 2011
Shampa Das, M P Lolkema, P O Witteveen
exaly  

Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview

Medicinal Research Reviews, 2017
Peter M. Fischer
exaly  

A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma

Cancer Cell, 2017
Shokat Kevan, Daphne Haas-Kogan, Erin F Simonds   +2 more
exaly  

The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway

Pharmacology & Therapeutics, 2002
Yasuharu Sasaki
exaly